New insights into the organophosphate-induced intermediate syndrome
, , , y | 07 jul 2018
Acerca de este artículo
Publicado en línea: 07 jul 2018
Páginas: 191 - 195
Recibido: 01 mar 2018
Aceptado: 01 may 2018
DOI: https://doi.org/10.2478/aiht-2018-69-3121
Palabras clave
© 2018 Raluca Ecaterina Haliga et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Raluca Ecaterina Haliga
Department of Internal Medicine and Toxicology, “Sf. Spiridon” Clinical Emergency Hospital,
University of Medicine and Pharmacy “Gr. T. Popa” IasiRomania
Bianca Codrina Morarasu
Department of Internal Medicine, “Sf. Spiridon” Clinical Emergency Hospital,
University of Medicine and Pharmacy “Gr. T. Popa” IasiRomania
Manuela Ursaru
Department of Radiology and Imaging, “Sf. Spiridon” Clinical Emergency Hospital,
University of Medicine and Pharmacy “Gr. T. Popa” IasiRomania
Viorica Irimioaia
Department of Neurology, “Sf. Spiridon” Clinical Emergency Hospital,
University of Medicine and Pharmacy “Gr. T. Popa” IasiRomania
Laurentiu Sorodoc
Department of Internal Medicine and Toxicology, “Sf. Spiridon” Clinical Emergency Hospital,
University of Medicine and Pharmacy “Gr. T. Popa” IasiRomania